Antrafenine

Overview

Antrafenine (Stakane) is a derivative of 2-(quinolin-4-ylamino) benzoate, and is an orally active anti-inflammatory and analgesic agent. Antrafenine protects mammalian epithelial cells from cell death upon exposure to influenza A virus A/WSN/33 ( H1N1 ). Antrafenine inhibits carrageenan-induced paw swelling in rats, and reduces exudate volume and total leukocyte infiltration in carrageenan- and calcium pyrophosphate dihydrate crystal-induced pleurisy in rats. Antrafenine can be used in studies related to influenza and pseudogout.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Viral Infection | Products > Disease Areas > Arthritis | Products > Disease Areas > Purine Metabolism | Products > Disease Areas > Pain | Products > Disease Areas > Influenza Virus Infection | Products > Disease Areas > Gout | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Drug Derivative | Products > Signaling Pathways > Influenza Virus

Product Information

• Catalog No.: HY-A0235
• CAS No.: 55300-29-3
• Molecular Formula: C30H26F6N4O2
• Molecular Weight: 588.54
• Purity: 99.76%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (4.25 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source